Table 2 Clinical characteristics of patients and details of CHC and RHC and HBO treatment
Sex | Age/Therapy | Age/End of Follow-up | Diagnosis | Treatment | HBO IndicationIndikation | End of Therapy | Time till Haematuria [m] | RTOG/Gray before HBOT | Admissions to Hospital | Number blood transfusions | Duration till HBO [m] | HBO Treatments | Follow Up [m] | Events/Follow-up | RTOG/Gray after HBO |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 68 | 70 | PCA | adj | RC | 08/2008 | 34 | 3 | 5 | 0 | 4 | 40 | 33 | no relapse | 0 |
M | 82 | 86 | PCA | prim | RC | 07/2004 | 54 | 3 | 3 | 0 | 15 | 24 | 53 | no relapse | 0 |
M | 73 | 81 | PCA | HDR | RC | 08/2002 | 11 | 4 | 4 | 2 | 33 | 24 | 100 | 1x haematuria 2007 | 3 |
W | 71 | 83 | CCA | adj | RC | 07/1997 | 30 | 3 | 3 | 0 | 28 | 128 | 142 | no relapse | 0 |
M | 80 | 86 | PCA | prim | RC | 07/1998 | 5 | 4 | 2 | 2 | 110 | 40 | 78 | no relapse | 0 |
M | 71 | 76 | PCA | adj | RC | 01/1999 | 76 | 4 | 2 | 1 | 36 | 35 | 28 | no relapse, †2010 | 0 |
W | 86 | 90 | UCA | adj | RC | 01/1990 | 234 | 4 | 3 | 2 | 0 | 6 | 29 | no relapse, †2012 | 0 |
M | 80 | 83 | PCA | adj | RC | 01/2000 | 124 | 4 | 3 | 3 | 1 | 51 | 16 | SRC 2010, †2012 | 4 |
M | 65 | 72 | PCA | adj | RC | 03/2000 | 50 | 4 | 3 | 1 | 30 | 26 | 94 | no relapse | 0 |
M | 61 | 63 | PCA | sal | RC | 02/2010 | 20 | 4 | 3 | 4 | 7 | 20 | 133 | no relapse | 0 |
M | 22 | 33 | RPSS | comb | RC/CC | 01/1999 | 43 | 4 | 2 | 12 | 11 | 34 | 28 | no relapse | 0 |
M | 73 | 78 | PCA | sal | RC/RP | 07/2007 | 14 | 3 | 2 | 2 | 1 | 48 | 68 | no relapse | 0 |
M | 65 | 71 | PCA | adj | RC/RP | 07/2003 | 48 | 4 | 3 | 2 | 3 | 20 | 49 | no relapse, †2011 | 0 |
W | 49 | 56 | LE | prim | CC | 01/1974 | 362 | 3 | 4 | 0 | 40 | 40 | 86 | 1x haematuria 2008 | 3 |
M | 39 | 49 | WG | prim | CC | 01/1993 | 120 | 4 | 3 | 1 | 4 | 17 | 136 | no relapse | 0 |